Cardiac Wire #26 October 10, 2022
Challenging the Salt Restriction Norm | Speech Analysis App Predicts HF
Cardiac Wire #25 October 6, 2022
SGLT2i: A Universal HF Solution? | ECG-AI Boosts AFib Detection
Cardiac Wire #24 September 30, 2022
Plaque Reimbursement Milestone | Spironolactone for Alcohol Use Disorder
Cardiac Wire #23 September 28, 2022
Deprescribing Aspirin | Rocket Acquires Renovacor
Cardiac Wire #22 September 23, 2022
Aggressive LDL Reduction Strategy | Smart Stethoscopes
Cardiac Wire #21 September 21, 2022
Renal Denervation’s Comeback | TCT Announcement Surge
Cardiac Wire #20 September 15, 2022
Exercise is Medicine | Cardiac Nuclear-CT Guidelines
Cardiac Wire #19 September 14, 2022
Polypill’s Simplicity Advantage | Medtronic Adds BioButton to Portfolio
Cardiac Wire #18 September 11, 2022
GRACE 3.0: Correcting the Default Male Risk | Biosense Webster’s OCTARAY
Cardiac Wire #17 September 2, 2022
Medtronic’s Defibrillation Innovation | ESC Study Drop
Cardiac Wire #16 August 31, 2022
ESC Study Surge | CV Health Goes Digital
Cardiac Wire #15 August 28, 2022
Statin Guideline Debate | Sudden Cardiac Death Genes
Cardiac Wire #14 August 24, 2022
Obesity Paradox Bias | COVID Heart Insights
Cardiac Wire #13 August 21, 2022
Echo Clues: Predicting Cardiac Amyloidosis | New Ventricular Tachycardia Treatment
Cardiac Wire #12 August 17, 2022
Clinician ‘Algorithm Aversion’ in HF Care | Dyad’s AI Echo Clearance
Cardiac Wire #11 August 12, 2022
For Genetic Tests, Size Matters | Reva’s Revival
Cardiac Wire #10 August 10, 2022
Heating Up: Two Heart Medications Increase Risk | Smart Heart Scale
Cardiac Wire #9 August 5, 2022
Physiological Pacing Momentum | Stiff Heart Breakthrough
Cardiac Wire #8 August 3, 2022
